Moderna
MRNA
1,140 hedge funds and large institutions have $93.5B invested in Moderna in 2021 Q3 according to their latest regulatory filings, with 322 funds opening new positions, 395 increasing their positions, 325 reducing their positions, and 74 closing their positions.
335% more first-time investments, than exits
New positions opened: 322 | Existing positions closed: 74
74% more capital invested
Capital invested by funds: $53.9B → $93.5B (+$39.7B)
26% more funds holding
Funds holding: 903 → 1,140 (+237)
22% more funds holding in top 10
Funds holding in top 10: 32 → 39 (+7)
22% more repeat investments, than reductions
Existing positions increased: 395 | Existing positions reduced: 325
3.19% more ownership
Funds ownership: 57.08% → 60.27% (+3.2%)
13% less call options, than puts
Call options by funds: $8.43B | Put options by funds: $9.72B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.76B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.58B |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.45B |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$887M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$557M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$1.35B |
| 2 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$1.11B |
| 3 |
TP
Theleme Partners
London,
United Kingdom
|
-$780M |
| 4 |
Morgan Stanley
New York
|
-$649M |
| 5 |
Renaissance Technologies
New York
|
-$438M |
MRNA Hedge Fund Activity: Q3 2021 in Review
1,140 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q3 2021, worth a combined $93.5B — up 74% from $53.9B a quarter earlier.
Buyers outnumbered sellers: 322 funds opened new MRNA positions and 74 closed out — a net gain of 248 holders — while 395 added to existing stakes and 325 trimmed.
The largest buyer was BlackRock, adding an estimated $2.76B. The largest seller was Baillie Gifford & Co, cutting an estimated $1.35B.
- 1,140 institutional investors held Moderna (MRNA) as of Q3 2021, up from 903 in Q2 2021.
- Funds reported $93.5B of Moderna stock for Q3 2021, up 74% quarter-over-quarter.
- 322 funds opened new Moderna positions in Q3 2021 and 74 closed out, a net change of +248 holders.
- The largest Moderna buyer in Q3 2021 was BlackRock, an estimated $2.76B added.
- The largest Moderna seller in Q3 2021 was Baillie Gifford & Co, an estimated $1.35B sold.
Based on aggregated 13F filings for Q3 2021.